Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Babita Kataria"'
Autor:
Ashima Jain Vidyarthi, Salman Khan, Babita Kataria, Mukesh Nandal, Vishal Phogat, Arghya Das, Rama Chaudhry
Publikováno v:
Journal of Pure and Applied Microbiology, Vol 17, Iss 3, Pp 1422-1428 (2023)
Over the past decade, novel pathogens causing infections in patients have been identified. Chryseobacterium is one such emerging pathogen that is frequently reported in hospitalized patients. Case reports of bloodstream infections, and pneumonia due
Externí odkaz:
https://doaj.org/article/0684caaac3ce4e93a0ff3bc69fc0ce21
Autor:
Salman Khan, Arghya Das, Deepali Vashisth, Anwita Mishra, Ashima Jain Vidyarthi, Raghav Gupta, Nazneen Nahar Begam, Babita Kataria, Sushma Bhatnagar
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303753 (2024)
NDM-producing carbapenem-resistant bacterial infections became a challenge for clinicians. Combination therapy of aztreonam and ceftazidime-avibactam is a prudent choice for these infections. However, there is still no recommendation of a practically
Externí odkaz:
https://doaj.org/article/da185dc630a94ffaa01bdf2e8f1fde46
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2016, Iss 10, Pp 1-4 (2016)
Externí odkaz:
https://doaj.org/article/f3a82e8591fd4044b96a925ca33b27d5
Autor:
Akash, Kumar, Saphalta, Baghmar, Prashant, Mehta, Priya, Tiwari, Lalit, Kumar, Sameer, Bakhshi, Amit, Agarwal, Ishaan, Gupta, Anjan, Trikha, Sushma, Bhatnagar, Ajay, Gogia, Prabhat Singh, Malik, Ranjit Kumar, Sahoo, Sameer, Rastogi, Raja, Pramanik, Atul, Batra, Deepam, Pushpam, Chitresh K, Sharma, Vinod, Sharma, Babita, Kataria, Kapil, Goyal, Shreyas, Samaga, Sneha J, Bothra, Atul, Sharma
Publikováno v:
The Indian journal of medical research. 155(6)
High mortality has been observed in the cancer population affected with COVID-19 during this pandemic. We undertook this study to determine the characteristics and outcomes of cancer patients with COVID-19 and assessed the factors predicting outcome.
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:560-568
Introduction Soft tissue sarcoma(STS) is a rare and heterogeneous group of disorders with dismal outcomes in metastatic setting. Pazopanib and oral metronomic chemotherapy (OMT) have been evaluated as therapeutic options in this cohort. Materials and
Autor:
Vinod Sharma, Akash Kumar, Annie Baa, Sudhir Kirar, Atul Sharma, Sameer Bakhshi, Ajay Gogia, Prabhat Singh Malik, Sameer Rastogi, Atul Batra, Deepam Pushpam, Babita Kataria, Hari Sagiraju, Aparna Sharma, Vishwajeet Singh
Publikováno v:
BMJ Supportive & Palliative Care. :spcare-2022
ObjectivesDexamethasone sparing strategies have shown success. The feasibility of a dexamethasone-free antiemetic strategy remains undetermined. A prospective, single-arm, pilot study was planned to determine the efficacy of an olanzapine-based, dexa
Publikováno v:
ecancermedicalscience
Background Uncommon histopathological subtypes account for less than 5% cases of soft tissue sarcoma (STS) and unclassified STSs comprise another 16%, these are often chemotherapy-resistant, with a dismal outcome in unresectable/metastatic disease. P
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2016, Iss 10, Pp 1-4 (2016)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 10 (2016)
Clinical Medicine Insights. Oncology
Clinical Medicine Insights: Oncology, Vol 10 (2016)
The development of acute myeloid leukemia has been attributed to various factors, including hereditary, radiation, drugs, and certain occupational exposures. The association between malignancy and venous thromboembolism events is well established. He
Autor:
Prabhat Singh Malik, Babita Kataria, Bivas Biswas, Deepak Dabkara, Valliappan Muthu, Sachin Khurana, Joydeep Ghosh, Sandip Ganguly, Navneet Singh, Kuruswamy Thurai Prasad, Saurav Verma
Publikováno v:
Current Problems in Cancer. 44:100565
Maintenance chemotherapy (MC) with pemetrexed is a commonly used strategy in nonsquamous non-small cell lung cancer. However, most of the available evidence is from subjects with good performance status (PS), while data on the real-world utility and
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S301